放射性颈动脉狭窄干预结局的系统综述与荟萃分析
该系统综述与荟萃分析纳入32篇文献共6695例患者,评估放射性颈动脉狭窄(RICS)患者行颈动脉内膜剥脱术(CEA)、经股动脉颈动脉支架置入术(CAS)及经颈动脉血运重建术后的结局。结果显示30天卒中率1.93%,再狭窄率10.51%,再干预率6.53%;CAS再干预率显著高于CEA,RICS患者再狭窄和再干预风险显著高于非放疗对照组。
要点
- RICS患者颈动脉血运重建围术期安全,30天卒中率1.93%。
- RICS患者远期再狭窄和再干预率约为动脉粥样硬化对照的3-4倍。
- CEA远期耐久性优于CAS,再干预率显著更低。
核心结论
- RICS患者颈动脉血运重建围术期结局与非放疗患者相似,但远期再狭窄和再干预率显著更高。
- CEA远期耐久性优于CAS。
研究设计与样本
- 系统综述与荟萃分析,纳入36个研究臂(32篇文献,6695例患者),评估30天及长期结局,采用纽卡斯尔-渥太华量表评估研究质量。
主要发现
- 汇总30天卒中率为1.93%(95%CI 1.36-2.74%),30天复合结局率为2.75%(95%CI 1.89-3.99%)。
- 再狭窄发生率为10.51%(95%CI 7.61-14.33%),再干预率为6.53%(95%CI 4.29-9.83%)。
- CAS再狭窄率数值上高于CEA(12.0% vs. 5.98%;P=0.05),再干预率显著更高(8.06% vs. 2.21%;P=0.004)。
- 与非放疗对照相比,RICS患者再狭窄(OR 3.13,95%CI 1.24-7.89;P=0.028)和再干预率(OR 3.86,95%CI 1.13-13.17;P=0.022)显著更高。
- 放疗至血运重建时间与再狭窄或再干预率无关(P=0.46和P=0.34)。
临床怎么用
- RICS患者行颈动脉血运重建围术期安全,但需重视远期再狭窄风险。
- CEA可能提供更好的远期耐久性,选择CAS时应加强随访。
- 建议对RICS患者进行密切的长期监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess clinical outcomes after carotid endarterectomy (CEA), transfemoral carotid artery stenting (CAS), and transcarotid artery revascularization in patients with radiation-induced carotid artery stenosis (RICS) utilizing a systematic review and meta-analysis. METHODS: A systematic review and meta-analysis of the literature was performed. We focused on 30-day and long-term outcomes. Study quality was assessed using the Newcastle-Ottawa Scale. RESULTS: Among 36 study-arms (32 publications, 6,695 patients), the pooled 30-day stroke rate was 1.93% (95% confidence interval [CI] 1.36-2.74%) and 30-day composite outcome rate was 2.75% (95% CI 1.89-3.99%). Restenosis occurred in 10.51% (95% CI 7.61-14.33%) and reintervention in 6.53% (95% CI 4.29-9.83%) of patients. Subgroup analysis showed numerically higher restenosis (12.0% vs. 5.98%; P = 0.05) and significantly higher reintervention rates (8.06% vs. 2.21%; P = 0.004) after CAS than CEA. In the comparative analysis against nonirradiated controls, perioperative outcomes were similar between groups; however, restenosis (odds ratio [OR] 3.13, 95% CI 1.24-7.89; P = 0.028) and reintervention rates (OR 3.86, 95% CI 1.13-13.17; P = 0.022) were significantly higher in RICS patients. Time from radiotherapy to revascularization was not associated with restenosis or reintervention rates (P = 0.46 and P = 0.34, respectively). CONCLUSION: Carotid revascularization in patients with RICS appears to be safe, with perioperative outcomes similar to those in nonirradiated patients. The main difference was in long-term follow-up, where restenosis and reintervention occur 3-4 times more frequently than in atherosclerotic controls. CEA also showed better long-term durability than CAS. These findings support close long-term surveillance in this population.
引用
- Inal E, Meschia JF, Jeevaratnam S, et al. Outcomes After Intervention in Radiation-Induced Carotid Artery Stenosis: A Systematic Review and Meta-Analysis. Ann Vasc Surg. 2026. PMID: 42637117. doi:10.1016/j.avsg.2026.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。